Hungary signs MoU on local Sinopharm vaccine production
Image by Zoltan Tarlacz / Shutterstock.com
Hungary has signed a memorandum of understanding on the local production of a COVID vaccine developed by China's Sinopharm, state secretary Tamás Menczer said in a post on Facebook on Friday.
Under the MoU, signed with Sinopharm-CNBG VP Jiang Xiuchang and CEO of Sinopharm-CNBG's joint venture in the UAE Peng Xiao, capacity and infrastructure to produce the vaccine will be set up in Hungary in 10 months, at the latest, Menczer said.
He noted that the partners in China and the UAE are continuously examining new mutations of the coronavirus and working to develop the most effective vaccines. That cooperation could give Hungary the chance to get fresh information on new mutations and adjust local production accordingly, rapidly and efficiently, he added.
Hungary CPI Drop Acknowledged at IMF/World Bank Spring Meeti...
Hungary to Address Future of Cohesion Policy During EU Presi...
AI may Save Hungarian Healthcare, Says Leading Doctor
Time Out Market to Open in Budapest Next Year
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
